Active

Fresenius SE & Co. KGaA

Investor type

CVC / VC

Founded

1912

AUM

-

Location

Bad Homburg, Hesse, Germany

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

Europe
Investor profile last updated: 25 July, 2026

Profile

Fresenius SE & Co. KGaA is a healthcare investor based in Germany, focusing on biopharma, medtech, and care provision sectors. Founded by Eduard Fresenius, the company's venture arm, Fresenius Ventures, is led by Dr. Thomas Michael Thestrup, who joined from Angelini Ventures. Fresenius Ventures sets itself apart by being a strategic corporate venture, aiming to act as a partner and eventual acquirer of startups in related healthcare fields, emphasizing a strong commitment to venture success.

Fresenius Ventures plans to allocate more than 200 million euros over five years into healthcare startups. They invest globally with Europe as a primary sourcing ground, focusing on precision nutrition, microbiome research, new therapeutic modalities, and digital care provision. The venture fund positions itself as an early through growth-stage investor, without specified check sizes, structured with flexibility across its main areas of interest.

Notable investments have not been specified yet, as Fresenius Ventures has just launched. However, the parent company, Fresenius, has been historically involved in strategic investments such as the acquisition of Merck KGaA's biosimilars pipeline and a stake in mAbxience. This strategic fund aims to continue that legacy by leveraging partnerships within its key sectors.

Industry

AI Pharmaceuticals Medical Devices Healthcare Services Digital Biotechnology MedTech

Fresenius SE & Co. KGaA Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Fresenius Ventures
Venture Capital (VC)
Corporate VC (CVC)
Biotechnology
Digital
Healthcare Services
Pharmaceuticals
MedTech
Seed
Series A
Series B
Europe
$10-50 m
$220 M
July 2026

Contacts

Name
Title
Email
avatar
Malgorzata Szum, ACCA, CIA Director Innovation & Operational Excellence
Director Innovation & Operational Excellence
m•••@•••
avatar
Carsten Bahr Director Corporate Development @ Fresenius Group
Director Corporate Development @ Fresenius Group
c•••@•••
Upgrade to see contacts
avatar
0Om4Qct2LYPTiaXq 0Om4Qct2LYPTiaXq
0Om4Qct2LYPTiaXq
avatar
0Om4Qct2LYPTiaXq 0Om4Qct2LYPTiaXq
0Om4Qct2LYPTiaXq
avatar
0Om4Qct2LYPTiaXq 0Om4Qct2LYPTiaXq
0Om4Qct2LYPTiaXq
Investment-team contacts for Fresenius SE & Co. KGaA — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a venture capital firm that also operates as a corporate VC (CVC). It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $10-50 m.
Fresenius SE & Co. KGaA is located in Bad Homburg, Hesse, Germany.
Fresenius SE & Co. KGaA was founded in 1912.
Fresenius SE & Co. KGaA invests in companies and startups in AI, Pharmaceuticals, Medical Devices, Healthcare Services, Digital, Biotechnology, MedTech.
Fresenius SE & Co. KGaA invests in companies and startups in Europe.
Fresenius SE & Co. KGaA invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).
Fresenius SE & Co. KGaA usually invests $10-50 m on average.
Fresenius SE & Co. KGaA last fund was created/launched in 2026-07-24
Fresenius SE & Co. KGaA can be reached through its website fresenius.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Fresenius SE & Co. KGaA — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Fresenius SE & Co. KGaA directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 25 July, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.